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eration for Environmental Movement,
Korea's largest environmental organization,
and now serves as the group's secretary-
general.
Island Nations: Noah Idechong. The
island of Palau, located in the Pacific
Ocean 600 miles east ofthe Philippines, is
home to coral reefs considered to have the
highest species diversity in the Pacific.
Although coral reefs cover only 0.17% of
the ocean floor, they are home to an esti-
mated quarter of all marine species. Palau
recently became the world's newest nation,
and foreign investors are rushing to devel-
op the area before environmental regula-
tions are in place. Noah Idechong, the for-
mer chief of Palau's Division of Marine
Resources, developed a model for marine
conservation to protect the island's coral
reefs and fisheries. Idechong convinced the
chiefs ofPalau to reinstate the conservation
traditions known as bu4 which limit fish-
ing in the spawning channels within the
villages' reefs. He also oversaw the installa-
tion ofmooring buoys at scuba-diving sites
to save coral from destruction by boat
anchors, and helped to secure passage of a
national sustainable marine resources bill,
the first government attempt in Palau's
2,000-year history to place restrictions on
fishermen. In 1994, Idechong resigned
from his government post to become the
director ofthe Palau Conservation Society,
Palau's major non-governmental environ-
mental organization.
Europe: Emma Must. On her way to
Winchester, England, every day to work as
a children's librarian, Emma Must passed
Twyford Down, a hillside that was known
for its unique natural habitats and archeo-
logical significance. In 1992, highway con-
struction through the down was begun,
despite local opposition. Must joined a
CD
small group ofpeople opposed to the con-
struction who camped on the hill to pre-
vent its destruction. After the group was
forcibly removed from the site, Must
began to organize large protests. By actions
such as chaining herself to a bulldozer,
Must brought national attention to the
issue. Though Twyford Down was not
saved, it served as a turning point in the
issue of road construction policy. Must
continued to organize the anti-road move-
ment and press for policy reforms. As a
result, 60 proposed road projects have been
canceled, and the road building budget has
been cut. In 1994, the Department of
Transport acknowledged that building new
roads increases traffic and environmental
hazards and is developing a national trans-
port strategy that is not based on building
new roads.
North America: Aurora Castillo. In
1984, Aurora Castillo, an East Los Angeles
native in her earlyeighties, learned thatwhat
would be the eighth prison in her Latino
community was being planned. Castillo
joined with two other women to oppose
construction of the proposed facility, form-
ing the group the Mothers of East Los
Angeles (MELA). MELA began organizing
women throughout the community, who
flooded public hearings to oppose the prison
construction anddemandpublic meetings in
Spanish. In 1992, the state of California
decided to locate the prison in another com-
munity. MELA, which now has over 400
members, continued to pressure the govern-
ment to relocate other undesirable facilities
such as a toxic waste incinerator being
planned for construction upwind from the
East Los Angeles community. MELA has
also been working in conjunction with local
industries to help create a more environmen-
tallyresponsible community.
South/Central America: Richard
Navarro. Twelve years ofcivil war has dev-
astated El Salvador's environment.
Recognizing the critical need to address his
country's environmental problems,
Richard Navarro founded the Salvadoran
Center for Appropriate Technology
(CESTA). CESTA works with rural and
urban communities on projects such as
construction of dry-composting latrines to
end chronic water contamination and pro-
motes organic agriculture to cut down on
the need for costly chemical inputs. For
the last several years, Navarro has been
engaged in a highly politicized struggle to
protect the last forested area near the capi-
tal, San Salvador, from development.
Navarro is also coordinating a living
memorial to the 75,000 people who have
died in the civil war. Young people in
Guazapa, a region left barren by heavy
napalm bombing, are working to plant a
"Forest ofReconciliation," in which a fruit
or medicinal tree will be planted for each
individual who has died in the war.
Nuclear Waste: A Cancer Cure?
In a marriage ofstrange bedfellows, scien-
tists at one ofthe country's most contami-
nated nuclear waste sites are collaborating
with medical researchers to turn nuclear
waste into an experimental therapy for can-
cer. Patients with Hodgkin's disease and
brain, ovarian, and breast cancers may be
able to receive the new radiation-based
treatment in the next five to ten years.
The Hanford nuclear site in Richland,
Washington, at one time produced pluto-
nium for the U.S. Department ofDefense.
Plutonium production has been halted,
but cleanup ofthe waste will cost over $50
billion and take more than 30 years. In an
2m
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effort to defray some costs and provide a
marketable product from the waste, Pacific
Northwest Laboratories (PNL) and
Westinghouse Hanford Company have
entered a joint venture to investigate
radioisotope production from the waste.
Radioisotopes are unstable elements that
emit particles of radiation. Currently,
about 90% of all medical radioisotopes
used in the United States are imported
from countries such as Russia and Canada.
Recently, scientists at the Hanford site
found a way to chemically extract a pure
form of the radioisotope yttrium-90 from
strontium-90, a by-product of plutonium
production. Yttrium-90 is being tested in
clinical trials at medical
centers around the
country as a treatment
for various types ofcan-
cers, and the initial
results are encouraging.
Radioactive materi-
als have been used in
medical procedures for
decades, but treatments
have often been dan-
gerous and results
unsatisfactory. Advan-
ces in medical tech-
nologies currently
allow radioisotopes to
be used safely and
effectively for over
36,000 diagnostic pro-
cedures per day in the
United States. These
procedures use very
low levels of radiation
to diagnose heart dis- Smart bullets. Mono
ease, cancer, complica- and treatment.
tions of AIDS, epilep-
sy, and infections.
The technique to extract pure yttrium-
90 from strontium-90 was discovered by
Lane Bray, a Hanford chemist. This tech-
nique produces the purest form ofyttrium-
90 in the world. The advantage ofyttrium-
90 over other radioisotopes is its short half-
life. Its radioactive emissions are halved
every 64 hours. Within a few days, the
amount of radioactivity it generates is too
small to be measured. The use of this iso-
tope for treatment of patients with recur-
ring Hodgkin's disease began in the early
1990s.
Radioactivity destroys cancer cells by
emitting particles that physically damage
any surrounding cell. Therefore, for suc-
cessful treatment with minimal side
effects, the radioisotope must be targeted
specifically to the tumor cells. This is
accomplished by the use of monoclonal
antibodies or proteins referred to as "smart
bullets." These proteins circulate in the
body and lock onto tumor cells, allowing
the attached radioisotope to act primarily
on the diseased tissue.
Hodgkin's disease is a cancer of the
lymph nodes that is often successfully
treated with the traditional methods of
chemotherapy and radiation. Patients who
were not helped by traditional treatments
were enrolled in a clinical trial ofyttrium-
90 at the MD Anderson Cancer Center in
Houston, Texas.
In the trial, patients were injected with
a diagnostic isotope linked to the treat-
ment antibody. This procedure determines
whether the treatment antibody will deliv-
er the yttrium-90 specifically to the cancer
site. So far, the antibody used in this trial
iclonal antibodies tagged with radioisotopes target cance
has been successful in targeting the cancer
in 100% of test cases. This same antibody
was then linked to yttrium-90 and inject-
ed. Patients were monitored by weekly
blood tests. Patients returned to the clinic
at two-month intervals for further injec-
tions of yttrium-90 if the cancer was still
present.
Yttrium-90 treatment produced posi-
tive results in about 85% of the 80
Hodgkin's disease patients that participat-
ed in the trial. Huibert Vriesendorp, a
radiation oncologist at MD Anderson who
conducted the trial, is encouraged by these
results. "The patients in the trial had failed
all other conventional cancer treatments
such as chemotherapy and radiation. These
patients have previously received very
aggressive treatments and are relieved to
find that the yttrium-90 treatment has rel-
atively few side effects and is patient-
friendly. The average survival rate of this
group of patients is six to eight months
longer than without treatment. A few
patients have successfully reached two years
with no recurrence ofthe cancer, but most
do have recurrences."
Most patients on the yttrium-90 treat-
ment respond after three or four series of
injections over several months. Although
currently used in patients with late-stage
cancers, Vriesendorp expects the treatment
to be at least as effective for patients in ear-
lier stages ofthe disease.
Another advantage of this type of out-
patient therapy is that it is highly cost
effective. According to Vriesendorp,
"Radiolabeled antibodies are much cheaper
than traditional cancer therapies. Insurance
companies are willing to pay for these pro-
cedures."
_| Additional trials
IE using yttrium-90-linked
I monoclonal antibodies
are underway at 10
s cancer centers, includ-
¢ ing Memorial Sloan
Kettering in NewYork,
the National Cancer
Institute in Maryland,
and the University of
Nebraska Medical Cen-
ter. According to Dennis
Wester, senior research
scientist at PNL, it may
take four more years of
human clinical trials
before the FDA ap-
proves yttrium-90 as a
standard cancer therapy.
The MD Anderson
Cancer Center has
applied for a $5 mil-
r cells for diagnosis lion NCI grant over
five years to expand its
study of yttrium-90 as
a weapon against brain and ovarian cancers
and should begin these studies shortly.
More trials for small-cell lung and breast
cancer patients are expected to begin in the
next year or two. "Another exciting appli-
cation of yttrium-90 therapy is for
rheumatoid arthritis," noted Vriesendorp.
"The stabilized isotope is injected directly
into the joint to attack the inflammatory
cells that are at the root ofthe disease."
On the horizon is a new isotope being
developed at Hanford called radium-223.
PNL researcher Darrell Fisher compares
the effect on cancer cells of yttrium-90 to
radium-223 as the difference between hit-
ting a house with a pellet gun and a wreck-
ing ball.
It is easier to bring patients to the iso-
tope than to send the treatment to pat-
ients. Because of the isotope's extremely
short half-life, Robert Schenter, medical
and research project manager at
Westinghouse Hanford, envisions a future
pilgrimage of cancer patients to a world-
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famous radioisotope clinic in the Richland
area.
Hints on Hantavirus
Researchers in Arizona are beginning a
two-year study to determine how rodent
infection with hantavirus varies with the
seasons, habitat, and temperature in hopes
that such information may help health
authorities better understand the risks to
humans.
Hantavirus is contracted by humans,
health authorities believe, by direct contact
with infected rodents or their urine or
feces. The disease caused by the virus,
known as hantavirus pulmonary syndrome
(HPS), has killed 54 people in the United
States, primarily in the West, although
James Mills, an epidemiologist specializing
in rodent-borne zoonotic diseases at the
Centers for Disease Control and Pre-
vention (CDC) in Atlanta, says rodents
carrying the virus have been found
throughout the country. HPS surfaced
approximately two years ago in an out-
break in the Southwest.
The study, funded by the CDC, will
focus on a number of different habitats
throughout Arizona, including the higher
elevations in northern Arizona and lower,
more arid regions in the southern part of
the state. Researchers will attempt to
answer a range of questions, according to
Michael Morrison, adjunct associate pro-
fessor ofwildlife biology at the University
of Arizona and one of the project's
researchers: "The CDC would like to
know how the frequency of the viral anti-
body changes in rodents throughout the
year. In summer, do twenty-five percent of
them have it? In winter, do ten percent of
them have it? The CDC would like to cor-
relate that with various changes in the ani-
mal population, weather conditions, and
the like."
This research is part of a larger pro-
gram in which scientists are gathering as
much information as possible on han-
tavirus. "We're slowly putting together the
picture ofa geographic location, habitat-
be it desert or chaparral or alpine tundra-
and seasonality, and looking at risk pat-
terns through time and space," says Mills.
"We can try to identify specific habitats
and specific times ofyear when risk is like-
ly to be higher than in other habitats and
times ofyear."
Researchers from the Arizona Depart-
ment ofHealth Services reported in March
that they found hantavirus-infected
rodents in a variety of habitats. In a pre-
liminary study, conducted in the summer
and early fall oflast year, researchers led by
Craig Levy, program manager of the
department's vector-borne and zoonotic
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WWW Hot Zone
Recent events such as the outbreak ofthe Ebolavirus in Zaire, which
has resulted in more than 100 deaths, and the makingofthebestsell-
ing book, The Hot Zone, by Richard Preston, into a Hollywood
movie about Ebola, have generated considerable interest among the
public about viruses. Scientists, however, have long been fascinated byviruses, and aWorld
Wide Web site constructed by the Institute for Molecular Virology at the University of
Wisconsin-Madison (URL:http://www.bocklabs.wisc.edufWelcome.html) is dedicated to
virology. This site provides a tremendous resource for researchers, academic faculty, stu-
dents, andanyoneelseinterested inviruses.
For the novice, the IMV site contains a compre-
hensive introduction to molecular virology through
a tutorial organized by Ed Rybicki of the
Department of Microbiology at the University of
Cape Town, which was originally written as a sup-
plement to his "Introduction to Virology' lecture
course for second-year undergraduate microbiology
majors. Other educational materials including dis-
cussions by the world's leading researchers on Ebola,
AIDS, hantavirus, and herpes viruses are provided
under the hyperlink "course notes andtutorials."
For more advanced users, there are virology-
related news andjournal articles, computervisualiza-
tions ofviruses, and digitized images ofviruses by
electron microscope. The hvuerlink "totooraohical
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maps" shows how such maps may be used to recon-
struct a complete icosahedral (60-face) viral particle from one face (shown in an image
on the site). Superior graphics and references to accompanyingjournal articles make this
avaluable link for researchers.
The IMVsite also provides a linkto several databases housing information on specif-
ic virus sequences, alignments, and phylogenetic trees, as well as a link to the classifica-
tion ofviruses by the International Committee on Taxonomy ofViruses. Users who
wish to contact virus experts may consult a phone book ofvirologists on the Internet,
and users who want to discuss their own research findings with others in the field can
sign on to a Bionet.virologyUSENET news group.
Additional resources beyond the scope ofthis site are available throughlinks tovirol-
ogy-related resources elsewhere on the Internet including links to emergingviruses infor-
mation and research, HIV/AIDS information and research, and research organizations
such as theWorld Health Organization andthe Centers for Disease Control.
disease section, found the highest infection
rates among rodents in a variety ofvegetat-
ed habitats in the northern part ofthe state
at elevations ranging from 4,000 to 10,000
feet above sea level. Infection rates ranged
from 8.4% to 13%.
In the desertlike southern part of
Arizona, infection rates were sharply re-
duced, ranging from 0 to 4.0%. However,
researchers are unsure whether this differ-
ence is a function ofhabitat or season and
believe the low infection rate may be
because the animals were trapped and test-
ed during the summer. During winter and
spring, researchers found higher infection
rates among rodents in southern Arizona
while conducting follow-ups of suspected
HPS cases. In one southern Arizona coun-
ty, 19% ofrodents trapped inJanuarywere
positive for hantavirus. The reason for the
seasonal difference is unknown. Tempera-
ture, humidity, and rodent activity may all
play a part, says Mira Leslie, an epidemiol-
ogist with the Arizona Department of
Health Services. But, Leslie notes, strains
ofhantavirus generally do follow a seasonal
pattern ofinfection.
Research on the impact of habitat on
rates of rodent infection will focus on a
dry area in southwestern Arizona that is
primarily a mesquite grassland. Trapping
sites will include an area around a season-
al creek as well as on a hillside. "What
we'll be able to do within that mesquite
grassland is look at more micro-site con-
ditions to see ifwhen the populations are
lower, there is a certain segment of the
rodent population that has a higher or
lower prevalence [of infection] than the
ones that live in the hillsides in the win-
ter," Morrison says.
Already, Morrison says, preliminary
evidence points to wild mice of the genus
Peromyscus that live along rivers and creeks
as possibly having a higher prevalence of
hantavirus infection than those living on
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